Pfizer Reportedly Manufactures ‘Several Hundred Thousand’ Covid-19 Vaccines Anticipating November Regulatory Approval

U.S. drug giant Pfizer has started work manufacturing hundreds of thousands of Covid-19 vaccines ahead of an expected U.S. approval in November, the Mail on Sunday reports.